MERCK & CO., INC., 11-K filed on 6/24/2026
Annual Report of Employee Stock Plans
v3.26.1
Cover
 12 Months Ended
Dec. 31, 2025
Document Information [Line Items]  
Document Type 11-K
Entity Registrant Name MERCK & CO., INC.
Entity Central Index Key 0000310158
Amendment Flag false
EBP 001  
Document Information [Line Items]  
Document Type 11-K
Entity tax identification number 22-1918501
Plan number 001
Entity Registrant Name MERCK & CO., INC.
Entity Central Index Key 0000310158
Amendment Flag false
v3.26.1
Statements of Net Assets Available for Benefits - EBP 001 - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
    Investments    
        Investment in Master Trust, at fair value $ 16,046,971 $ 14,892,909
    Receivables    
        Employer contributions 2,180 1,572
        Participant contributions 5,918 4,137
        Notes receivable from participants 77,410 72,299
            Total receivables 85,508 78,008
    Net assets available for benefits $ 16,132,479 $ 14,970,917
v3.26.1
Statement of Changes in Net Assets Available for Benefits - EBP 001
$ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
    Investment gain  
        Plan interest in Master Trust investment gain $ 2,392,957
    Interest income on notes receivable from participants 5,927
    Contributions to the Plan  
        By participants 664,661
        By employer 216,252
            Total contributions 880,913
    Transfers in 839
            Total additions 3,280,636
Deductions from net assets attributed to  
Participant withdrawals (2,118,968)
Administrative expenses (38)
    Transfers out (68)
            Total deductions (2,119,074)
            Net increase 1,161,562
Net assets available for benefits  
    Beginning of year 14,970,917
    End of year $ 16,132,479
v3.26.1
Description of Plan
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Description of Plan [Line Items]  
Description of Plan Description of Plan
The following description of the Merck US Savings Plan (the “Plan”) provides only general information. Participants should refer to the Plan document for a more complete description of the Plan’s provisions.
General
The Plan is designed to provide a systematic means of saving and investing for the future as well as an easy and economical way for employees to become shareholders of Merck & Co., Inc. (“Merck” or the “Company”). Regular full-time, part-time, and temporary employees as defined by the Plan document are eligible to participate in the Plan on or after their dates of hire or after they transfer into a U.S. benefits-eligible position. Merck is the Plan sponsor (the “Sponsor”).
Participants direct the investment of their contributions into any fund investment option available under the Plan, including Merck common stock. The Plan offers a three-tiered approach to investing:
*Retirement Portfolios - a custom set of target date retirement funds;
*Core Funds - a selection of investment options (active and passive) that span a range of asset classes;
*Fidelity Brokerage Link® - a self-directed brokerage account that provides access to more than 8,500 mutual funds.
The Plan is administered by management committees appointed by the Company’s Chief Executive Officer, the Compensation and Management Development Committee of the Board of Directors of Merck or their delegates.
The Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”).
Master Trust
The assets of the Plan are maintained, for investment purposes only, on a commingled basis with a portion of the MSD Puerto Rico Savings & Security Plan (the “Puerto Rico Plan”) and all of the assets of the MSD Employee Stock Purchase and Savings Plan in the Merck & Co., Inc. Qualified Plans Master Trust (the "Master Trust)". The plans own specific interests in the Master Trust assets.
The portion of Master Trust assets allocable to each plan is based upon the participants’ account balances within each plan. Investment income for the Master Trust is allocated to each plan based on the specific investments held in the Master Trust.
Contributions
Participants may contribute up to 25% of their annual eligible compensation through a combination of before-tax and Roth contributions (in 1% increments), up to the combined statutory elective deferral limit ($23,500 in 2025). Participants may also contribute up to 25% of their annual eligible compensation on an after-tax basis. Upon reaching the statutory elective deferral limit for combined before-tax and Roth contributions, the participant may elect to suspend contributions for the remainder of the year or elect to continue on an after-tax basis. The sum of before-tax, Roth and after-tax contributions cannot exceed 50% of annual eligible compensation.
In addition, the Company makes matching contributions of $0.75 for every $1.00 of an employee's contributions, up to 6% of such employee's eligible compensation (maximum match is 4.5% of eligible compensation) per pay period (to the statutory limit). The combination of before-tax, Roth, after-tax and Company matching contributions may not exceed the statutory limit ($70,000 in 2025). Participant and Company matching contributions are invested according to a participant’s elections.
Participants are automatically enrolled in the Plan sixty days after first becoming eligible with a before-tax base pay contribution rate of 6%. In addition, each participant with a before-tax base pay contribution rate of at least 1% may elect to participate in an annual automatic increase program, in whole percentages of at least 1% and not more than 3% per year. The annual percentage increase continues automatically up to 10%. The participant may elect to change or extend it up to 25%. This feature applies to before-tax bonus and base pay contributions.
In addition, the Plan permits matched before-tax and Roth "catch-up contributions" of up to the statutory limit ($7,500 in 2025) by participants who are at least age 50 by year-end. Participants who turn age 60-63 during a calendar year are allowed to make up to $3,750 in additional before-tax and Roth catch-up contributions for those years, after which the maximum amount returns to the normal level.
Participant Accounts
Each participant’s account is credited with the participant’s contributions, the Company’s contributions and an allocation of Plan earnings. The allocation is based on participants’ account balances, as defined in the Plan document.
Vesting
Participants are immediately vested in their contributions, all Company matching contributions, plus actual earnings thereon.
Notes Receivable from Participants
Participants may borrow from their account balances with interest charged at the prime rate in effect on the last business day of the prior month plus 1%. Once set, the interest rate is in effect for the duration of the loan. Loan terms range from one to five years for a short-term loan or up to fifteen years for the purchase of a primary residence and bear interest at rates that range from 4.25% to 10.50%. The minimum loan is $1,000 and the maximum loan is the lesser of (i) $50,000 less the highest outstanding loan balance(s) during the one-year period prior to the new loan application date, or (ii) 50% of the participant’s account balance less any current outstanding loan balance(s) and defaulted loan amounts. Principal and interest are paid ratably through payroll deductions. Loan terms are grandfathered into the Plan in accordance with the legacy plan guidelines, including loan terms for participants that transferred into the Plan from a legacy plan.
Payment of Benefits
Participants are entitled to receive automatic, voluntary, in-service (which include hardship withdrawals), or mandatory distributions as provided in the applicable Plan provisions.
Transfers
Transfers in and out during 2025 relate primarily to transfers between the Plan and the MSD Employee Stock Purchase and Savings Plan for employees who changed their status during the year.
v3.26.1
Summary of Accounting Policies
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Accounting Policy [Line Items]  
Summary of Accounting Policies Summary of Accounting Policies
Basis of Accounting
The accompanying financial statements are prepared on the accrual basis of accounting.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities at the date of the financial statements. Management believes that these estimates are adequate. Actual results could differ from those estimates.
Investment Valuation and Income Recognition
All investments are recorded at fair value in the accompanying financial statements. Valuation of investments of the Plan represents the Plan’s specific interest in the Master Trust. The Plan’s investment in the Master Trust is stated at fair value and is based on the beginning of year value of the Plan’s interest in the Master Trust plus actual Plan contributions and specific investment income less Plan distributions, specific investment losses and allocated expenses.
Purchases and sales of securities are recorded on a trade-date basis. Dividend income is recorded on the ex-dividend date. Interest income is recorded as earned. Realized gains and losses from security transactions are reported on the average cost method.
Notes Receivable from Participants
Notes receivable from participants are measured at their unpaid principal balance plus any accrued but unpaid interest. Delinquent participant loans are reclassified as benefit payments based upon the terms of the Plan document. No allowance for credit losses has been recorded as of December 31, 2025 and 2024.
Contributions
Employee and Company matching contributions are recorded in the year in which participant compensation is earned.
Payment of Benefits
Benefits are recorded when paid.
Administrative Expenses

Administrative expenses primarily include certain recordkeeping and loan fees along with other fees and credits. Other administrative expenses are paid by the Company.

Risks and Uncertainties
The Plan provides for various investment options in investment securities. Investment securities, in general, are exposed to various risks and may decline in value for a number of reasons, including changes in prevailing interest rates and credit availability, increases in defaults, increases in voluntary prepayments for investments that are subject to prepayment risk under normal market conditions, widening of credit spreads and overall market volatility. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participants’ account balances and the amounts reported in the Statements of Net Assets Available for Benefits.
v3.26.1
Related-Party Transactions
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Related Party and Party-in-Interest Transactions [Line Items]  
Related-Party Transactions Related-Party Transactions
Contributions are held and managed by Fidelity Management Trust Company (“Fidelity” or the “Trustee”), which invests cash received, interest and dividend income and makes distributions to the participants. The Trustee also administers the participants’ payment of interest and principal on the notes receivable from participants. These transactions qualify as permitted party-in-interest transactions.
Certain Plan investments are shares of registered investment companies (mutual funds) and common/collective trusts managed by the Trustee or its affiliates. Fidelity is the trustee as defined by the Plan and, therefore, these transactions qualify as party-in-interest transactions. The total market value of the Plan’s portion of the investments managed by the Trustee was $794.1 million and $648.3 million at December 31, 2025 and 2024, respectively. During 2025, the Plan’s portion of interest and dividends, realized and unrealized gains from investments managed by the Trustee was $10.5 million, $21.9 million and $197.8 million, respectively.
Merck also is a party-in-interest to the Plan under the definition provided in Section 3(14) of ERISA. Therefore, Plan transactions of Merck common stock qualify as both related party transactions and party-in-interest transactions. The market value of the Plan’s portion of the investment in Merck common stock was $812.0 million and $926.9 million at December 31, 2025 and 2024, respectively. During 2025, the Plan’s portion of dividends, realized gains and unrealized losses from Merck common stock was $28.0 million, $77.6 million and $53.3 million, respectively. The Plan’s portion of purchases and sales of Merck common stock during 2025 was $28.7 million and $162.6 million, respectively.
v3.26.1
Plan Termination
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Description of Plan [Line Items]  
Plan Termination Plan Termination Although it has not expressed any intent to do so, the Company has the right under the Plan to discontinue its contributions at any time and to terminate the Plan subject to the provisions of ERISA. Upon termination of the Plan, each participant thereby affected would receive the entire value of his or her account as though he or she had retired as of the date of such termination.
v3.26.1
Tax Status
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Tax Status [Line Items]  
Tax Status Tax Status
The Plan obtained a tax determination letter from the Internal Revenue Service (“IRS”) dated February 8, 2018, indicating that the Plan had been designed in accordance with applicable sections of the Internal Revenue Code (“IRC”). The Plan has been amended since receiving the determination letter. However, the Sponsor believes that the Plan is designed and currently operates in compliance with the IRC. Therefore, no provision for income taxes has been made.
Accounting principles generally accepted in the United States of America require Plan management to evaluate tax positions taken by the Plan and recognize a tax liability (or asset) if the Plan has taken an uncertain position that more likely than not would not be sustained upon examination by the IRS. The Plan administrator has analyzed the tax positions taken by the Plan and has concluded that, as of December 31, 2025 and 2024, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liability (or asset) or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions. The Plan administrator believes the Plan is no longer subject to income tax examinations for years prior to 2022.
v3.26.1
Master Trust
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Master Trust [Line Items]  
Master Trust Master Trust
The net assets of the Master Trust and the Plan's interest are as follows:
2025
(in thousands)Master TrustMerck US Savings Plan Interest
Registered investment companies (mutual funds)$97,747 $91,946 
Common/collective trusts12,677,091 12,108,089 
Equity securities2,307,397 2,189,256 
Fixed income securities406,994 386,758 
Self-directed brokerage accounts459,800 435,989 
Merck common stock907,977 812,041 
Accrued interest and dividends15,877 14,659 
Other net assets8,648 8,233 
$16,881,531 $16,046,971 
2024
(in thousands)Master TrustMerck US Savings Plan Interest
Registered investment companies (mutual funds)$500,106 $474,904 
Common/collective trusts11,107,463 10,620,120 
Equity securities2,244,340 2,130,066 
Fixed income securities386,182 367,820 
Self-directed brokerage accounts368,784 352,416 
Merck common stock1,026,831 926,902 
Accrued interest and dividends17,180 15,934 
Other net assets4,994 4,747 
$15,655,880$14,892,909
Total investment income (loss) of the Master Trust for the year ended December 31, 2025, is as follows:
2025
Master Trust
(in thousands)
Investment income
    Net appreciation$2,354,281 
    Interest and dividends157,490 
        Total investment income$2,511,771 
v3.26.1
Fair Value Measurements
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Investment, Fair Value and NAV [Line Items]  
Fair Value Measurements Fair Value Measurements
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Entities are required to use a fair value hierarchy that maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:
Level 1 – Quoted prices in active markets for identical assets or liabilities. The Master Trust's Level 1 investments primarily include registered investment companies (mutual funds), self-directed brokerage accounts and common stocks.
Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. The Master Trust's Level 2 investments primarily include investments in certain fixed income investments such as government and agency obligations, corporate obligations and mortgage and asset-backed securities.
Level 3 – Unobservable inputs that are supported by little or no market activity and that are financial instruments whose values are determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant judgment or estimation. The Master Trust did not hold any Level 3 investments at December 31, 2025 and 2024.
If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. There have been no changes in the valuation methodologies used at December 31, 2025 and 2024.
Within the Master Trust, investments are recorded at fair value as follows:
Registered Investment Companies (Mutual Funds)
Registered investment companies (mutual funds) are valued at their respective net asset values. The net asset values are typically determined by the fund at the close of regular trading. Investments in registered investment companies (mutual funds) generally may be redeemed daily.
Common/Collective Trusts
The common/collective trusts are valued at their respective net asset values, as a practical expedient for fair value. The fair value of investments in the common/collective trusts are determined by their trustee. The Master Trust's investments in common/collective trusts generally may be redeemed daily.
Fixed Income Securities
Fixed income securities, including U.S. government and agency obligations, corporate obligations and mortgage and asset-backed securities, are generally valued on the basis of valuations furnished by a pricing service approved by the Trustee or at fair value as determined in good faith by the Trustee and the Company. The Trustee has the discretionary authority to hire a pricing service to determine valuations using methods based on current market transactions, prices for comparable securities and various relationships between securities which are generally recognized by institutional traders.
Self-Directed Brokerage Accounts
Self-directed brokerage accounts are comprised of mutual funds, which are valued at the net asset value reported by the managers of the funds, typically determined at the close of regular trading.
Equity Securities / Common Stocks
Common stocks, for which market quotations are readily available, are generally valued at the last reported sales price on their principal exchange on the valuation date, or official close price for certain markets. If no sales are reported for that day, these investments are valued at the more recent of (i) the last published sale price or (ii) the mean between the last reported bid and asked prices for long positions, or at fair value as determined in good faith by the Trustee and the Company.
Master Trust Investments Measured at Fair Value
Master Trust investments measured at fair value as of December 31, 2025 are summarized below:
December 31, 2025
Fair Value Measurements Using
(in thousands)Quoted PricesTotal
In ActiveSignificant
Markets forOtherSignificant
Identical ObservableUnobservable
AssetsInputsInputs
(Level 1)(Level 2)(Level 3)
Investments in the Master Trust
Registered investment companies$97,747 $— $— $97,747 
Equity securities2,307,397 — — 2,307,397 
Fixed income securities— 406,994 — 406,994 
Self-directed brokerage accounts459,800 — — 459,800 
Merck common stock907,977 — — 907,977 
Investments measured within the fair value hierarchy$3,772,921$406,994$— $4,179,915
Common/collective trusts measured at NAV practical expedient (1)
$12,677,091
Master trust investments at fair value$16,857,006 
(1) Certain investments that were measured at net asset value (NAV) per share or its equivalent have not been classified in the fair value hierarchy. The fair value amounts presented in this table also do not include the Master Trust's accrued interest and dividends or other net assets.
The Plan's interests within the Master Trust as specifically identified in Note 6 are leveled in the same manner as the Master Trust investment categories presented above.
Master Trust Investments Measured at Fair Value
Master Trust investments measured at fair value as of December 31, 2024 are summarized below:
December 31, 2024
Fair Value Measurements Using
(in thousands)Quoted PricesTotal
In ActiveSignificant
Markets forOtherSignificant
Identical ObservableUnobservable
AssetsInputsInputs
(Level 1)(Level 2)(Level 3)
Investments in the Master Trust
Registered investment companies$500,106 $— $— $500,106 
Equity securities2,244,340 — — 2,244,340 
Fixed income securities— 386,182 — 386,182 
Self-directed brokerage accounts368,784 — — 368,784 
Merck common stock1,026,831 — — 1,026,831 
Investments measured within the fair value hierarchy$4,140,061$386,182$— $4,526,243
Common/collective trusts measured at NAV practical expedient (1)
11,107,463
Master trust investments at fair value$15,633,706 
(1) Certain investments that were measured at net asset value (NAV) per share or its equivalent have not been classified in the fair value hierarchy. The fair value amounts presented in this table also do not include the Master Trust's accrued interest and dividends or other net assets.
The Plan's interests within the Master Trust as specifically identified in Note 6 are leveled in the same manner as the Master Trust investment categories presented above.
v3.26.1
Subsequent Events
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Subsequent Event [Line Items]  
Subsequent Events Subsequent Events
The Plan has evaluated subsequent events through the date the financial statements were issued and no events were noted which warrant adjustments to, or disclosure in the financial statements.
v3.26.1
Schedule H, Line 4i – Schedule of Assets (Held At End of Year)
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Schedule of Asset Held for Investment [Line Items]  
Schedule H, Line 4i – Schedule of Assets (Held At End of Year)
Merck US Savings PlanSchedule H
Schedule H, Line 4i - Schedule of Assets (Held at End of Year)
December 31, 2025
(a)(b)(c)(d)(e)
Identity of Issue, Borrower, Lessor or Similar PartyDescription of Investment Including Maturity Date, Rate of Interest, Collateral, Par or Maturity ValueCostCurrent Value
**Master TrustInvestment in Master Trust***$16,046,970,628 
*Notes receivable from participants
Interest rates ranging from 4.25% to 10.50% and with maturities through 2048
77,409,564 
Total$16,124,380,192 
*Denotes a party-in-interest to the Plan.
**There are certain investments within the Master Trust that are party-in-interest.
***Cost information not required to be presented for participant directed investments.
v3.26.1
Summary of Accounting Policies (Policies) - EBP 001
 12 Months Ended
Dec. 31, 2025
EBP, Accounting Policy [Line Items]  
Basis of Accounting
Basis of Accounting
The accompanying financial statements are prepared on the accrual basis of accounting.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and changes therein, and disclosure of contingent assets and liabilities at the date of the financial statements. Management believes that these estimates are adequate. Actual results could differ from those estimates.
Investment Valuation and Income Recognition
Investment Valuation and Income Recognition
All investments are recorded at fair value in the accompanying financial statements. Valuation of investments of the Plan represents the Plan’s specific interest in the Master Trust. The Plan’s investment in the Master Trust is stated at fair value and is based on the beginning of year value of the Plan’s interest in the Master Trust plus actual Plan contributions and specific investment income less Plan distributions, specific investment losses and allocated expenses.
Purchases and sales of securities are recorded on a trade-date basis. Dividend income is recorded on the ex-dividend date. Interest income is recorded as earned. Realized gains and losses from security transactions are reported on the average cost method.
Notes Receivable from Participants
Notes Receivable from Participants
Notes receivable from participants are measured at their unpaid principal balance plus any accrued but unpaid interest. Delinquent participant loans are reclassified as benefit payments based upon the terms of the Plan document. No allowance for credit losses has been recorded as of December 31, 2025 and 2024.
Contributions
Contributions
Employee and Company matching contributions are recorded in the year in which participant compensation is earned.
Payment of Benefits
Payment of Benefits
Benefits are recorded when paid.
Administrative Expenses
Administrative Expenses

Administrative expenses primarily include certain recordkeeping and loan fees along with other fees and credits. Other administrative expenses are paid by the Company.
Risks and Uncertainties
Risks and Uncertainties
The Plan provides for various investment options in investment securities. Investment securities, in general, are exposed to various risks and may decline in value for a number of reasons, including changes in prevailing interest rates and credit availability, increases in defaults, increases in voluntary prepayments for investments that are subject to prepayment risk under normal market conditions, widening of credit spreads and overall market volatility. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect participants’ account balances and the amounts reported in the Statements of Net Assets Available for Benefits.
v3.26.1
Master Trust (Tables)
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Master Trust [Line Items]  
Schedule of master trust net assets
The net assets of the Master Trust and the Plan's interest are as follows:
2025
(in thousands)Master TrustMerck US Savings Plan Interest
Registered investment companies (mutual funds)$97,747 $91,946 
Common/collective trusts12,677,091 12,108,089 
Equity securities2,307,397 2,189,256 
Fixed income securities406,994 386,758 
Self-directed brokerage accounts459,800 435,989 
Merck common stock907,977 812,041 
Accrued interest and dividends15,877 14,659 
Other net assets8,648 8,233 
$16,881,531 $16,046,971 
2024
(in thousands)Master TrustMerck US Savings Plan Interest
Registered investment companies (mutual funds)$500,106 $474,904 
Common/collective trusts11,107,463 10,620,120 
Equity securities2,244,340 2,130,066 
Fixed income securities386,182 367,820 
Self-directed brokerage accounts368,784 352,416 
Merck common stock1,026,831 926,902 
Accrued interest and dividends17,180 15,934 
Other net assets4,994 4,747 
$15,655,880$14,892,909
Total investment income (loss) of the Master Trust for the year ended December 31, 2025, is as follows:
2025
Master Trust
(in thousands)
Investment income
    Net appreciation$2,354,281 
    Interest and dividends157,490 
        Total investment income$2,511,771 
v3.26.1
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2025
EBP 001  
EBP, Investment, Fair Value and NAV [Line Items]  
Schedule of master trust investments measured at fair value
Master Trust investments measured at fair value as of December 31, 2025 are summarized below:
December 31, 2025
Fair Value Measurements Using
(in thousands)Quoted PricesTotal
In ActiveSignificant
Markets forOtherSignificant
Identical ObservableUnobservable
AssetsInputsInputs
(Level 1)(Level 2)(Level 3)
Investments in the Master Trust
Registered investment companies$97,747 $— $— $97,747 
Equity securities2,307,397 — — 2,307,397 
Fixed income securities— 406,994 — 406,994 
Self-directed brokerage accounts459,800 — — 459,800 
Merck common stock907,977 — — 907,977 
Investments measured within the fair value hierarchy$3,772,921$406,994$— $4,179,915
Common/collective trusts measured at NAV practical expedient (1)
$12,677,091
Master trust investments at fair value$16,857,006 
(1) Certain investments that were measured at net asset value (NAV) per share or its equivalent have not been classified in the fair value hierarchy. The fair value amounts presented in this table also do not include the Master Trust's accrued interest and dividends or other net assets.
The Plan's interests within the Master Trust as specifically identified in Note 6 are leveled in the same manner as the Master Trust investment categories presented above.
Master Trust investments measured at fair value as of December 31, 2024 are summarized below:
December 31, 2024
Fair Value Measurements Using
(in thousands)Quoted PricesTotal
In ActiveSignificant
Markets forOtherSignificant
Identical ObservableUnobservable
AssetsInputsInputs
(Level 1)(Level 2)(Level 3)
Investments in the Master Trust
Registered investment companies$500,106 $— $— $500,106 
Equity securities2,244,340 — — 2,244,340 
Fixed income securities— 386,182 — 386,182 
Self-directed brokerage accounts368,784 — — 368,784 
Merck common stock1,026,831 — — 1,026,831 
Investments measured within the fair value hierarchy$4,140,061$386,182$— $4,526,243
Common/collective trusts measured at NAV practical expedient (1)
11,107,463
Master trust investments at fair value$15,633,706 
(1) Certain investments that were measured at net asset value (NAV) per share or its equivalent have not been classified in the fair value hierarchy. The fair value amounts presented in this table also do not include the Master Trust's accrued interest and dividends or other net assets.
The Plan's interests within the Master Trust as specifically identified in Note 6 are leveled in the same manner as the Master Trust investment categories presented above.
v3.26.1
Description of Plan (Details) - EBP 001
 12 Months Ended
Dec. 31, 2025
USD ($)
EBP, Description of Plan [Line Items]  
Participant contribution, pretax, maximum annual compensation to total compensation, percentage 25.00%
Increment of maximum annual compensation to total compensation, percentage 1.00%
Participant contribution, aftertax, maximum annual compensation to total compensation, percentage 25.00%
Employer contribution, matching percentage per US dollar $ 0.75
Employer contribution, participant compensation matched, percentage 6.00%
Employer contribution, matching percentage 4.50%
Participant contribution, provision period before deferrals begin 60 days
Participant contribution, automatic, deferral rate 6.00%
Participant contribution, automatic, deferral rate, maximum annual automatic increase 10.00%
Basis spread on variable rate 1.00%
Short term loan, borrowing term 1 year
Receivable from participant, account, primary residence, maximum borrowing term 15 years
Receivable from participant, account, minimum borrowing, amount $ 1,000
Receivable from participant, account, maximum borrowing, amount $ 50,000
Note receivable from participant, account, maximum borrowing, to total account, percentage 50.00%
Minimum  
EBP, Description of Plan [Line Items]  
Participant contribution, automatic, deferral rate, annual automatic increase 1.00%
Short term loan, borrowing term 1 year
Notes receivable from participants, interest rate 4.25%
Maximum  
EBP, Description of Plan [Line Items]  
Participant contribution, maximum contribution to eligible compensation, percentage 50.00%
Participant contribution, automatic, deferral rate, annual automatic increase 3.00%
Short term loan, borrowing term 5 years
Notes receivable from participants, interest rate 10.50%
v3.26.1
Related-Party Transactions (Details) - EBP 001 - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Trustee    
EBP, Related Party and Party-in-Interest Transactions [Line Items]    
        Investment in Master Trust, at fair value $ 794.1 $ 648.3
Increase from dividend income on investment 10.5  
Realized gain on investment 21.9  
Unrealized gain on investment 197.8  
Merck common stock    
EBP, Related Party and Party-in-Interest Transactions [Line Items]    
        Investment in Master Trust, at fair value 812.0 $ 926.9
Increase from dividend income on investment 28.0  
Realized gain on investment 77.6  
Unrealized gain on investment 53.3  
Purchase price 28.7  
Sale of common stock $ 162.6  
v3.26.1
Master Trust - Schedule of Master Trust Net Assets (Details) - EBP 001 - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
EBP, Master Trust [Line Items]    
    Net assets available for benefits $ 16,132,479 $ 14,970,917
Master Trust    
EBP, Master Trust [Line Items]    
Accrued interest and dividends 15,877 17,180
Other net assets 8,648 4,994
    Net assets available for benefits 16,881,531 15,655,880
Master Trust | Registered investment companies (mutual funds)    
EBP, Master Trust [Line Items]    
Investments, at fair value 97,747 500,106
Master Trust | Common/collective trusts    
EBP, Master Trust [Line Items]    
Investments, at fair value 12,677,091 11,107,463
Master Trust | Equity securities    
EBP, Master Trust [Line Items]    
Investments, at fair value 2,307,397 2,244,340
Master Trust | Fixed income securities    
EBP, Master Trust [Line Items]    
Investments, at fair value 406,994 386,182
Master Trust | Self-directed brokerage accounts    
EBP, Master Trust [Line Items]    
Investments, at fair value 459,800 368,784
Master Trust | Merck common stock    
EBP, Master Trust [Line Items]    
Investments, at fair value 907,977 1,026,831
Merck US Savings Plan Interest    
EBP, Master Trust [Line Items]    
Accrued interest and dividends 14,659 15,934
Other net assets 8,233 4,747
    Net assets available for benefits 16,046,971 14,892,909
Merck US Savings Plan Interest | Registered investment companies (mutual funds)    
EBP, Master Trust [Line Items]    
Investments, at fair value 91,946 474,904
Merck US Savings Plan Interest | Common/collective trusts    
EBP, Master Trust [Line Items]    
Investments, at fair value 12,108,089 10,620,120
Merck US Savings Plan Interest | Equity securities    
EBP, Master Trust [Line Items]    
Investments, at fair value 2,189,256 2,130,066
Merck US Savings Plan Interest | Fixed income securities    
EBP, Master Trust [Line Items]    
Investments, at fair value 386,758 367,820
Merck US Savings Plan Interest | Self-directed brokerage accounts    
EBP, Master Trust [Line Items]    
Investments, at fair value 435,989 352,416
Merck US Savings Plan Interest | Merck common stock    
EBP, Master Trust [Line Items]    
Investments, at fair value $ 812,041 $ 926,902
v3.26.1
Master Trust - Schedule of Net Investment Gain (Details) - EBP 001
$ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
EBP, Master Trust [Line Items]  
    Net appreciation $ 2,392,957
Master Trust  
EBP, Master Trust [Line Items]  
    Net appreciation 2,354,281
    Interest and dividends 157,490
        Total investment income $ 2,511,771
v3.26.1
Fair Value Measurements (Details) - EBP 001 - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value $ 16,857,006 $ 15,633,706
Fair Value, Inputs, Level 1, Level 2, and Level 3    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 4,179,915 4,526,243
Fair Value, Inputs, Level 1, Level 2, and Level 3 | Registered investment companies    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 97,747 500,106
Fair Value, Inputs, Level 1, Level 2, and Level 3 | Equity securities    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 2,307,397 2,244,340
Fair Value, Inputs, Level 1, Level 2, and Level 3 | Fixed income securities    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 406,994 386,182
Fair Value, Inputs, Level 1, Level 2, and Level 3 | Self-directed brokerage accounts    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 459,800 368,784
Fair Value, Inputs, Level 1, Level 2, and Level 3 | Merck common stock    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 907,977 1,026,831
Quoted Prices In Active Markets for Identical Assets (Level 1)    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 3,772,921 4,140,061
Quoted Prices In Active Markets for Identical Assets (Level 1) | Registered investment companies    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 97,747 500,106
Quoted Prices In Active Markets for Identical Assets (Level 1) | Equity securities    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 2,307,397 2,244,340
Quoted Prices In Active Markets for Identical Assets (Level 1) | Fixed income securities    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
Quoted Prices In Active Markets for Identical Assets (Level 1) | Self-directed brokerage accounts    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 459,800 368,784
Quoted Prices In Active Markets for Identical Assets (Level 1) | Merck common stock    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 907,977 1,026,831
Significant Other Observable Inputs (Level 2)    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 406,994 386,182
Significant Other Observable Inputs (Level 2) | Registered investment companies    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
Significant Other Observable Inputs (Level 2) | Equity securities    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
Significant Other Observable Inputs (Level 2) | Fixed income securities    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 406,994 386,182
Significant Other Observable Inputs (Level 2) | Self-directed brokerage accounts    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
Significant Other Observable Inputs (Level 2) | Merck common stock    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
Significant Unobservable Inputs (Level 3)    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
Significant Unobservable Inputs (Level 3) | Registered investment companies    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
Significant Unobservable Inputs (Level 3) | Equity securities    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
Significant Unobservable Inputs (Level 3) | Fixed income securities    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
Significant Unobservable Inputs (Level 3) | Self-directed brokerage accounts    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
Significant Unobservable Inputs (Level 3) | Merck common stock    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value 0 0
NAV | Common/collective trusts    
EBP, Investment, Fair Value and NAV [Line Items]    
Master trust investments at fair value $ 12,677,091 $ 11,107,463
v3.26.1
Schedule H, Line 4i – Schedule of Assets (Held At End of Year) (Details) - EBP 001
 12 Months Ended
Dec. 31, 2025
USD ($)
EBP, Schedule of Asset Held for Investment [Line Items]  
Master trust, current value $ 16,046,970,628
Notes receivable from participants, current value 77,409,564
Total current value $ 16,124,380,192
Minimum  
EBP, Schedule of Asset Held for Investment [Line Items]  
Notes receivable from participants, interest rate 4.25%
Maximum  
EBP, Schedule of Asset Held for Investment [Line Items]  
Notes receivable from participants, interest rate 10.50%